Cormorant Asset Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-115,000
| Closed | -$5.37M | – | 50 |
|
|
2023
Q2 | $5.37M | Buy |
+115,000
| New | +$5.37M | 0.3% | 48 |
|
|
2022
Q3 | – | Sell |
-403,787
| Closed | -$3.82M | – | 73 |
|
|
2022
Q2 | $3.82M | Hold |
403,787
| – | – | 0.29% | 55 |
|
|
2022
Q1 | $5.73M | Hold |
403,787
| – | – | 0.44% | 48 |
|
|
2021
Q4 | $8.54M | Sell |
403,787
-196,213
| -33% | -$4.15M | 0.51% | 47 |
|
|
2021
Q3 | $13.4M | Hold |
600,000
| – | – | 0.54% | 45 |
|
|
2021
Q2 | $14.9M | Sell |
600,000
-142,549
| -19% | -$3.54M | 0.51% | 44 |
|
|
2021
Q1 | $21.5M | Hold |
742,549
| – | – | 0.48% | 43 |
|
|
2020
Q4 | $19.2M | Sell |
742,549
-117,001
| -14% | -$3.02M | 0.46% | 45 |
|
|
2020
Q3 | $26.5M | Buy |
859,550
+267,011
| +45% | +$8.22M | 1.02% | 29 |
|
|
2020
Q2 | $14.8M | Sell |
592,539
-50,000
| -8% | -$1.25M | 0.56% | 46 |
|
|
2020
Q1 | $13.6M | Sell |
642,539
-98,082
| -13% | -$2.08M | 0.63% | 40 |
|
|
2019
Q4 | $16.4M | Hold |
740,621
| – | – | 0.66% | 36 |
|
|
2019
Q3 | $16.8M | Sell |
740,621
-27,221
| -4% | -$619K | 1.03% | 27 |
|
|
2019
Q2 | $14.7M | Buy |
+767,842
| New | +$14.7M | 0.84% | 33 |
|